Vaccine Therapy With or Without Sargramostim in Treating Patients With High-Risk or Metastatic Melanoma
Clinical trial NCT00037037 · UNKNOWN
Trial details
- NCT number
- NCT00037037
- Sponsor
- Herbert Irving Comprehensive Cancer Center
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2001-10-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.